Overview
Lobbying Costs
5,503,206€
Financial year: Jan 2017 - Dec 2017
Lobbyists (Full time equivalent)
15.75 Fte (30)
Lobbyists with EP accreditation
8
High-level Commission meetings
118
Lobbying Costs over the years
-
Info
European Federation of Pharmaceutical Industries and Associations (EFPIA)
EU Transparency Register
38526121292-88 First registered on 04 Mar 2009
Goals / Remit
EFPIA operates as the representative organisation of the research based pharmaceutical industry in Europe. The aim of the Federation, which has no profit-making purpose, is to promote pharmaceutical discovery and development in Europe and to promote a European regulatory environment, which facilitates innovative medicinal products to the market in order to improve human health worldwide.
In addition, EFPIA pursues a mainly scientific aim, ensuring and promoting the technological and economic development of the pharmaceutical industry in Europe. EFPIA’s activities extend to all matters of common interest to its members. In particular, it aims to foster an environment that encourages pharmaceutical research and development, manufacture in compliance with high quality standards, intellectual property protection and the introduction of regulatory requirements to allow patients rapid access to medicinal products.
EFPIA has developed Guidance for its members and it is available on its website.Main EU files targeted
Any health or pharmaceutical policy stemming from the European Institutions such as life sciences strategy, industrial policy, European Semester, Horizon Europe Research Programme, HTA policy, IP policy etc. EFPIA also follows ongoing trade negotiations and legislative files when relevant to the innovative pharmaceutical industry (such as Water Framework Directive, Welfare of animals in scientific testing etc).
Address
Head Office
8 Rue Mil Neuf Cents
Luxembourg L-2157
LUXEMBOURGEU Office
Rue du Trône 108
Brussels 1050
BELGIUM -
People
Total lobbyists declared
30
Employment time Lobbyists 100% 2 75% 5 50% 17 25% 6 Lobbyists (Full time equivalent)
15.75
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
8 accreditations were / are live (in bold) for the selected state of 05 Apr 2019
Name Start date End Date Sibilia QUILICI 14 Oct 2024 07 Nov 2024 Laurent Louette 02 Sep 2024 07 Nov 2024 Alexandra Tamas 13 Sep 2024 07 Nov 2024 Nathalie Moll 12 Jun 2024 07 Nov 2024 Athina Giannoutsou 26 Jun 2024 07 Nov 2024 Martina D'Amore 12 Jun 2024 07 Nov 2024 Katja Standke 12 Jun 2024 07 Nov 2024 Roberta SAVLI 12 Jun 2024 07 Nov 2024 Laurent David Louette 26 May 2023 25 May 2024 Thomas Allvin 01 Mar 2024 04 Oct 2024 Martina D'Amore 27 May 2023 25 May 2024 Athina Giannoutsou 05 Oct 2023 04 Oct 2024 Alexandra Tamas 06 Sep 2023 06 Sep 2024 Sophie Millar 05 Oct 2023 04 Oct 2024 Sibilia QUILICI 18 Oct 2023 04 Oct 2024 Nathalie Moll 13 May 2023 11 May 2024 Kristine PEERS 15 Jul 2023 12 Jul 2024 Athina Giannoutsou 20 Sep 2022 20 Sep 2023 Roberta SAVLI 04 May 2023 04 May 2024 Ms Katja STANDKE 13 Apr 2023 26 Apr 2024 Thomas Allvin 24 Jan 2023 24 Jan 2024 Ms Athina Giannoutou 20 Sep 2022 11 Sep 2023 Alexandra Tamas 06 Aug 2022 05 Aug 2023 Sophie Millar 16 Jul 2022 15 Jul 2023 Laurent David Louette 25 May 2022 25 May 2023 Martina D'Amore 31 May 2022 27 May 2023 Sibilia QUILICI 31 May 2022 31 May 2023 Ms Anna VICERE 25 May 2022 25 May 2023 Mr Laurent David M Louette 25 May 2022 10 Jun 2022 Mr Giacomo Borgo 24 May 2022 24 May 2023 Nathalie Moll 24 May 2022 13 May 2023 Roberta SAVLI 22 Apr 2022 22 Apr 2023 Mr PEDRO MANUEL DIAS DE FIGUEIREDO PEREIRA MARQUES 22 Apr 2022 22 Apr 2023 Alexandra Tamas 14 Aug 2021 06 Aug 2022 Sophie Millar 24 Jul 2021 16 Jul 2022 Mr Koen BERDEN 08 Jun 2021 08 Jun 2022 Martina D'Amore 04 Jun 2021 31 May 2022 Nathalie Moll 04 Jun 2021 24 May 2022 Sibilia QUILICI 11 May 2021 11 May 2022 Ms Anna VICERE 06 May 2021 06 May 2022 Ms Elizabeth Maria KUIPER 05 May 2021 12 Mar 2022 Mr Giacomo Borgo 05 May 2021 30 Apr 2022 Kristine PEERS 05 May 2021 30 Apr 2022 Ms Magdalena CHLEBUS 05 May 2021 30 Apr 2022 Mr Carlos PARRY LAFONT 29 Oct 2020 05 May 2021 Mr Koen BERDEN 15 Feb 2020 01 Mar 2021 Ms Magdalena RODRIGUEZ DE AZERO MACHADO 04 Feb 2020 04 Feb 2021 Ms anna swierczyna 01 Feb 2020 30 Jan 2021 Lenka CHRISTIAENS 09 Jan 2020 09 Jan 2021 Kristine PEERS 05 Oct 2019 03 Oct 2020 Ms Tea Jardas 05 Oct 2019 03 Oct 2020 Mr Giacomo Borgo 05 Oct 2019 03 Oct 2020 Ms Sofia MARCHA 24 Aug 2019 01 Sep 2020 Ms Anna JEDRUSIK 22 Aug 2019 31 Jan 2020 Ms Magdalena CHLEBUS 21 Aug 2019 01 Sep 2020 Nathalie Moll 16 Jul 2019 16 Jul 2020 Mr Giacomo Borgo 01 Dec 2018 05 Oct 2019 Lenka CHRISTIAENS 06 Nov 2018 06 Nov 2019 Ms Tea Jardas 06 Nov 2018 05 Oct 2019 Ms Sofia MARCHA 12 Sep 2018 24 Aug 2019 Kristine PEERS 12 Sep 2018 12 Sep 2019 Ms Anna JEDRUSIK 12 Sep 2018 22 Aug 2019 Ms Ioana Enache 01 Aug 2018 31 Oct 2018 Ms Magdalena CHLEBUS 18 Jul 2018 18 Jul 2019 Nathalie Moll 08 Jun 2018 08 Jun 2019 Ms Gabriella Seo ALMBERG 27 Oct 2017 20 Oct 2018 Lenka CHRISTIAENS 27 Oct 2017 20 Oct 2018 Ms Ioana Enache 31 Aug 2017 01 Aug 2018 Ms Magda Chlebus 20 Jul 2017 06 Jul 2018 Nathalie Moll 05 May 2017 01 May 2018 Ms Gabriella Seo ALMBERG 28 Oct 2016 27 Oct 2017 Ms Raquel Silva Resendes 20 Oct 2016 10 Jun 2017 Ms Ioana Enache 22 Aug 2016 19 Aug 2017 Ms Magda Chlebus 19 Jan 2016 18 Jan 2017 Mr Richard Arne BERGSTRÖM 11 Dec 2015 09 Dec 2016 Mr Brendan Barnes 27 Nov 2015 30 Nov 2016 Ms Elise Celia Melon 25 Nov 2015 19 Nov 2016 Ms Gabriella Seo ALMBERG 17 Oct 2015 15 Oct 2016 Ms Raquel Silva Resendes 17 Oct 2015 14 Oct 2016 Ms Ioana Enache 29 Jul 2015 27 Jul 2016 Ms Gabriella Seo ALMBERG 28 Oct 2014 17 Oct 2015 Ms Magda Chlebus 21 Jan 2015 19 Jan 2016 Mrs Gabriella Seo ALMBERG 28 Oct 2014 27 Jan 2015 Mr Brendan Barnes 24 Oct 2014 22 Oct 2015 Ms Elise Celia Melon 24 Oct 2014 22 Oct 2015 Ms Raquel Silva Resendes 22 Oct 2014 17 Oct 2015 Ms Anna Krózser 06 Sep 2014 30 May 2015 Mr Richard Arne BERGSTRÖM 17 Jun 2014 13 Jun 2015 Mrs Magdalena Chlebus 06 Dec 2013 05 Dec 2014 Mrs Gabriella Seo ALMBERG 30 Oct 2013 28 Oct 2014 Ms Raquel Silva Resendes 30 Oct 2013 22 Oct 2014 Mr Brendan Barnes 05 Sep 2013 04 Sep 2014 Mrs Angela Lorena PIEDRA HERNANDEZ 11 Sep 2013 10 Sep 2014 Mr Richard Arne BERGSTRÖM 04 Jul 2013 17 Jun 2014 Isabelle CLAMOU 04 Apr 2013 13 Oct 2013 Isabelle CLAMOU 07 Mar 2012 02 Apr 2013 Mrs Gabriella Seo ALMBERG 31 Jan 2013 27 Oct 2013 Ms Raquel Silva Resendes 23 Nov 2012 27 Oct 2013 Mrs Gabriella Seo ALMBERG 31 Jan 2012 08 Feb 2013 Mrs Angela Lorena PIEDRA HERNANDEZ 31 Jan 2012 08 Feb 2013 Mr Richard Arne BERGSTRÖM 30 Jan 2012 08 Feb 2013 Isabelle CLAMOU 07 Mar 2012 29 Mar 2013 Complementary Information
EFPIA’s Team is constituted of 48 employees, including 4 dedicated to Vaccines Europe and 4 dedicated to EBE, both “specialised groups” within EFPIA. As these groups are registered separately, staff dedicated to their activities are not included in the EFPIA reporting.
EFPIA employees that are not (9) involved in activities within scope of the Register or only occasionally i.c. spending less than 10% of their work time with EU Institutions (4) are not included in the number of persons. .
Numbers show the situation per 31 December 2017 for the financial year 2017.Person in charge of EU relations
Ms Nathalie Moll (Director General)
Person with legal responsibility
Mr Oschmann Stefan (President)
-
Categories
Category
II - In-house lobbyists and trade/business/professional associations
Subcategory
Trade and business associations
-
Networking
Affiliation
BIAC
British Chamber of Commerce
DIA
EACD
EAPM
EPC
FAIB
Friends of Europe
Kangaroo Group
TOPRA
European Risk Forum
THE EUROPEAN HOUSE - AMBROSETTIMember organisations
None declared
-
Financial Data
Closed financial year
Jan 2017 - Dec 2017
Lobbying costs for closed financial year
5,503,206€
Other financial info
EFPIA recommends that, along with EFPIA, each of its constituent entities – including corporate members, member associations and members of specialised groups – register in their individual capacity.
EFPIA, has developed Guidance to its members. The Guidance aims at supporting consistent and transparent reporting among EFPIA members, and will be made public. EFPIA Guidance followed the provisions in the renewed Interinstitutional Agreement between the European Parliament and the EU Commission, and builds on the recommendations of the Joint Transparency Register Secretariat.
Information included in the EFPIA Registration complies with the EFPIA Guidance. EFPIA will provide detailed information upon request.
The EFPIA specialised groups have registered separately: EBE with public ID number 768792210017-73 and Vaccines Europe (VE) with public ID number 53073567234-18. Since specialised groups have no legal responsibility, their registration is under the legal responsibility of EFPIA. However, EBE and VE will be registered as separate “subsidiaries”, with cross-referencing links.
Constituent entities that are not included in the EU “Transparency Register” shall not be part of EFPIA delegations interacting with the EU Commission / EP.
-
EU Structures
Groups (European Commission)
Group of Experts on EU Trade Agreements #E03556 #http://ec.europa.eu/transparency/regexpert/index.cfm?do=groupDetail.groupDetail&groupID=3556 #Member #C#Consultation Forum on Access and benefit sharing (ABS)#E03396 #http://ec.europa.eu/transparency/regexpert/index.cfm?do=groupDetail.groupDetail&groupID=3396 #Member #C#Competent Authorities' Expert Group on the protection of animals used for scientific purposes#E02539 #http://ec.europa.eu/transparency/regexpert/index.cfm?do=groupDetail.groupDetail&groupID=2539 #Observer #C#Strategic Coordination Group for the Water Framework and Floods Directives#E00371 #http://ec.europa.eu/transparency/regexpert/index.cfm?do=groupDetail.groupDetail&groupID=371 #Not a member #C#Chemicals#Technical Expert Group for the implementation of the Directive on the protection of animals used for scientific purposes#E02551 #http://ec.europa.eu/transparency/regexpert/index.cfm?do=groupDetail.groupDetail&groupID=2551 #Member #C#European Alcohol and Health Forum#E02224 #http://ec.europa.eu/transparency/regexpert/index.cfm?do=groupDetail.groupDetail&groupID=2224 #Member #C#Expert group on follow-up activities related to Corporate Responsibility in the field of Pharmaceuticals #E02558 #http://ec.europa.eu/transparency/regexpert/index.cfm?do=groupDetail.groupDetail&groupID=2558 #Member #C#Multistakeholder expert group to support the application of Regulation (EU) 2016/679#E03537 #http://ec.europa.eu/transparency/regexpert/index.cfm?do=groupDetail.groupDetail&groupID=3537 #Member #C
Groups (European Parliament)
None
Communication activities
Events with European Institutions as partners on health related topics.
Other activities
EFPIA covers regularly the committee debates in the European Parliament and attends public hearings, conferences, roundtables that are important to the industry. EFPIA also meets regularly Members of the European Parliament and assistants to facilitate the dialogue with the policy makers.
EFPIA has also regular interaction with the European Commission services including DG GROW, DG SANTE, DG RTD, DG TRADE, DG ENV, etc.- Meetings
Meetings
118 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.
-
Date 21 Mar 2024 Location Virtual Subject Sanctions Cabinet Cabinet of Commissioner Mairead Mcguinness Attending - Patricia Reilly (Cabinet member)
- Katherine Power (Cabinet member)
-
Date 03 Apr 2023 Location Brussels Subject Review of EU pharmaceutical regulations Cabinet Cabinet of Commissioner Mairead Mcguinness Portfolio Financial services, financial stability and Capital Markets Union Attending - Patricia Reilly (Cabinet member)
-
Date 21 Mar 2023 Location Brussels Subject Revision of the pharmaceutical legislation Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Attending - Maria Luisa Llano Cardenal (Cabinet member)
- Despina Spanou (Cabinet member)
-
Date 17 Mar 2023 Location Brussels Subject competitiveness, intellectual property protection, FTAs Cabinet Cabinet of Executive Vice-President Valdis Dombrovskis Portfolio An Economy that Works for People Attending - Kevin Keary (Cabinet member)
-
Date 16 Mar 2023 Location Brussels (VTC) Subject Boosting competitiveness and productivity in the EU pharmaceutical industry Cabinet Cabinet of President Ursula von der Leyen Portfolio President Attending - Anthony Whelan (Cabinet member)
-
Date 16 Mar 2023 Location Brussels (VTC) Subject Boosting competitiveness and productivity in the pharmaceutical industry -EFPIA's report Cabinet Cabinet of President Ursula von der Leyen Portfolio President Attending - Anthony Whelan (Cabinet member)
-
Date 10 Feb 2023 Location Brussels Subject employment aspects of the upcoming Pharmaceutical legislation Cabinet Cabinet of Commissioner Nicolas Schmit Portfolio Jobs and Social Rights Attending - Antoine Kasel (Cabinet member)
-
Date 10 Feb 2023 Location Brussels Subject Discussion of upcoming pharmaceutical package; value of predictability (IP), EU pharmaceutical product approval process, competitiveness, unmet medical needs. Cabinet Cabinet of Commissioner Mairead Mcguinness Portfolio Financial services, financial stability and Capital Markets Union Attending - Patricia Reilly (Cabinet member)
Other Lobbyists -
Date 09 Feb 2023 Location Brussels Subject Pharma package, competitiveness Cabinet Cabinet of Executive Vice-President Valdis Dombrovskis Portfolio An Economy that Works for People Attending - Kevin Keary (Cabinet member)
- Caroline Boeshertz (Cabinet member)
-
Date 08 Feb 2023 Location Brussels Subject Presenting the industry’s point of view on the upcoming pharmaceutical package and on the wider competitiveness, global positioning and resilience aspects. Cabinet Cabinet of Commissioner Johannes Hahn Portfolio Budget and Administration Attending - Kyriacos Charalambous (Cabinet member)
-
Date 02 Feb 2023 Location Brussels Subject Overview of EFPIA’s views on revision of EU pharmaceutical legislation; regulation, competitiveness, new drug development, research and innovation activities in Europe. Cabinet Cabinet of Commissioner Mairead Mcguinness Portfolio Financial services, financial stability and Capital Markets Union Attending - Patricia Reilly (Cabinet member)
-
Date 01 Feb 2023 Location Brussels Subject Discussion of the upcoming pharmaceutical legislative package Cabinet Cabinet of Commissioner Mairead Mcguinness Portfolio Financial services, financial stability and Capital Markets Union Attending - Patricia Reilly (Cabinet member)
-
Date 17 Oct 2022 Location Virtual Subject EFPIA/EC catch-up on HERA Next meeting of the Joint Cooperation Industrial Forum DG Health Emergency Preparedness and Response Authority Attending - Pierre Delsaux (Director-General)
-
Date 10 Oct 2022 Location Brussels (WEBEX) Subject Conc. Commission proposals to revise the entire EU pharmaceutical legislation by the end of the year Cabinet Cabinet of President Ursula von der Leyen Portfolio President Attending - Kurt Vandenberghe (Cabinet member)
-
Date 29 Jun 2022 Location Brussels Subject Pharma Strategy Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Attending - Margaritis Schinas (Vice-President)
- Maria Luisa Llano Cardenal (Cabinet member)
-
Date 29 Jun 2022 Location Brussels Subject Exchange of views on the upcoming pharmaceutical legislation Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
-
Date 11 May 2022 Location on-line meeting Subject Exchange of views on the upcoming pharmaceutical strategy. Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Giorgios Rossides (Cabinet member)
- Karolina Herbout-Borczak (Cabinet member)
-
Date 06 May 2022 Location Online Subject European Health Data Space, Data Act, Data Governance Act Cabinet Cabinet of Executive Vice-President Margrethe Vestager Portfolio Europe Fit for Digital Age Attending - Werner Stengg (Cabinet member)
-
Date 29 Mar 2022 Location online meeting Subject access to medicines online portal Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Attending - Despina Spanou (Cabinet member)
- Maria Luisa Llano Cardenal (Cabinet member)
-
Date 16 Mar 2022 Location Brussels (virtual via Webex) Subject EU Pharmaceutical Strategy DG Health and Food Safety Attending - Sandra Gallina (Director-General)
-
Date 14 Mar 2022 Location Webex Subject Meeting with EFPIA, Medicines for Europe and European Fine Chemical Group to discuss the security of supply of medicines Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
- Karolina Herbout-Borczak (Cabinet member)
-
Date 26 Oct 2021 Location Brussels Subject Pharmaceutical sector – trade related issues Cabinet Cabinet of Executive Vice-President Valdis Dombrovskis Portfolio An Economy that Works for People Attending - Caroline Boeshertz (Cabinet member)
- Kevin Keary (Cabinet member)
- Elina Melngaile (Cabinet member)
Other Lobbyists -
Date 21 Jun 2021 Location Brussels Subject Pharmaceutical strategy Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Attending - Margaritis Schinas (Vice-President)
- Maria Luisa Llano Cardenal (Cabinet member)
-
Date 16 Jun 2021 Location online Subject Supply chains for medicines Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Attending - Margaritis Schinas (Vice-President)
- Maria Luisa Llano Cardenal (Cabinet member)
Other Lobbyists -
Date 07 Jun 2021 Location Brussels Subject VTC meeting - Access to Medicines Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 17 May 2021 Location Video conferencing Subject EU vaccine policy Cabinet Cabinet of Executive Vice-President Valdis Dombrovskis Portfolio An Economy that Works for People Attending - Caroline Boeshertz (Cabinet member)
- Cristina Rueda Catry (Cabinet member)
- Michael Hager (Cabinet member)
-
Date 08 Apr 2021 Location online Subject Health Union Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Attending - Catherine Sustek (Cabinet member)
- Margaritis Schinas (Vice-President)
Other Lobbyists -
Date 25 Mar 2021 Location virtual meeting Subject Biopharmaceutical CEO Roundtable Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Attending - Despina Spanou (Cabinet member)
- Maria Luisa Llano Cardenal (Cabinet member)
-
Date 05 Mar 2021 Location Brussels Subject VC Meeting discussion on COVID-19 vaccines export authorisation scheme. Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 12 Feb 2021 Location Brussels (virtual) Subject Phone call with EFPIA DG Health and Food Safety Attending - Sandra Gallina (Director-General)
-
Date 06 Nov 2020 Location Brussels - virtual Subject Videoconference with Pharmaceutical Industry Associations to discuss shortages of medicines and medical devices including diagnostic tests in the context of COVID-19 pandemic Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 23 Oct 2020 Location VTC Subject Stronger “European health union” Cabinet Cabinet of Commissioner Olivér Várhelyi Portfolio Neighbourhood and Enlargement Attending - Szabolcs Horvath (Cabinet member)
-
Date 22 Oct 2020 Location Brussels (Webex) Subject Exchange of views on the upcoming pharmaceutical strategy Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Karolina Herbout-Borczak (Cabinet member)
- Giorgios Rossides (Cabinet member)
Other Lobbyists -
Date 20 Oct 2020 Location Virtual meeting Subject Pharmaceutical strategy Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Attending - Despina Spanou (Cabinet member)
- Maria Luisa Llano Cardenal (Cabinet member)
-
Date 15 Oct 2020 Location Online meeting Subject Conference on the Future of Europe Health and industrial policies Cabinet Cabinet of Vice-President Dubravka Šuica Portfolio Democracy and Demography Attending - Astrid Dentler (Cabinet member)
- Mattia De Grassi (Cabinet member)
-
Date 06 Oct 2020 Location Brussels Subject Pharmaceuticals strategy, Industrial strategy and trade policy issues Cabinet Cabinet of Executive Vice-President Margrethe Vestager Portfolio Europe Fit for Digital Age Attending - Nele Eichhorn (Cabinet member)
-
Date 30 Sep 2020 Location Online Subject Call with pharmaceutical and medical device supply Chain on COVID-19 Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Giorgios Rossides (Cabinet member)
- Karolina Herbout-Borczak (Cabinet member)
- Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 23 Sep 2020 Location Webex Subject Meeting on the upcoming Pharmaceutical Strategy. Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Karolina Herbout-Borczak (Cabinet member)
Other Lobbyists -
Date 23 Sep 2020 Location Brussels (video conference) Subject EU pharmaceutical strategy and the general approach to IP in pharmaceuticals Cabinet Cabinet of President Ursula von der Leyen Portfolio President Attending - Kurt Vandenberghe (Cabinet member)
-
Date 18 Sep 2020 Location Videoconference Subject Pharmaceutical strategy Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Eszter Batta (Cabinet member)
-
Date 03 Jul 2020 Location Brussels Subject VC meeting : Exchange of views on the forthcoming Pharmaceutical Strategy Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
-
Date 29 Jun 2020 Location Online Subject Call with pharmaceutical and medical device industry associations on COVID-19 Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Karolina Herbout-Borczak (Cabinet member)
- Stella Kyriakides (Commissioner)
- Giorgios Rossides (Cabinet member)
Other Lobbyists -
Date 29 Jun 2020 Location Brussels Subject Videoconference with Pharmaceutical Industry Associations to discuss shortages of medicines and medical devices including diagnostic tests in the context of COVID-19 pandemic Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 10 Jun 2020 Location Brussels Subject Webex meeting upon EFPIA’s request to discuss the forthcoming Pharmaceutical Strategy, the evaluation of the EU Orphan Medicinal Products and Paediatrics regulations and the proposed HTA regulation Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Giorgios Rossides (Cabinet member)
- Karolina Herbout-Borczak (Cabinet member)
-
Date 08 Jun 2020 Location Videoconference Subject Exchange of views on the new pharmaceutical strategy for Europe Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Attending - Maria Luisa Llano Cardenal (Cabinet member)
- Despina Spanou (Cabinet member)
-
Date 05 Jun 2020 Location Brussels (virtual meeting) Subject pharmaceutical strategy of the Commission, SWD on the Orphan and Paediatric Regulation DG Health and Food Safety Attending - Anne Bucher (Director-General)
-
Date 29 May 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 19 May 2020 Location Videomeeting Subject To discuss EU Pharmaceutical Strategy and EU Chemical Strategy and cooperation on green agenda. Cabinet Cabinet of Commissioner Virginijus Sinkevičius Portfolio Environment, Oceans and Fisheries Attending - Camilla Bursi (Cabinet member)
- Virginijus Sinkevičius (Commissioner)
-
Date 15 May 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 08 May 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 08 May 2020 Location Videoconference Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
Other Lobbyists -
Date 05 May 2020 Location Phone call Subject courtesy call and presentation by EFPIA of their concerns due to COVID crisis and the future of pharmaceutical industry DG Internal Market, Industry, Entrepreneurship and SMEs Attending - Kerstin Jorna (Director-General)
-
Date 29 Apr 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 29 Apr 2020 Location Videconference Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
Other Lobbyists -
Date 24 Apr 2020 Location Brussels Subject Covid-19 DG Research and Innovation Attending - Jean-Eric Paquet (Director-General)
-
Date 23 Apr 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 23 Apr 2020 Location Videconference Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
Other Lobbyists -
Date 17 Apr 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 09 Apr 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 09 Apr 2020 Location Videoconference Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
Other Lobbyists -
Date 03 Apr 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 03 Apr 2020 Location Videoconference Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
Other Lobbyists -
Date 02 Apr 2020 Location Brussels (phone call) Subject update on Pharma Strategy DG Health and Food Safety Attending - Anne Bucher (Director-General)
-
Date 27 Mar 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 27 Mar 2020 Location Videoconference Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
Other Lobbyists -
Date 20 Mar 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 20 Mar 2020 Location Videoconference Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
Other Lobbyists -
Date 13 Mar 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 28 Feb 2020 Location Brussels Subject EFPIA requested a meeting to present their ongoing work Cabinet Cabinet of Commissioner Jutta Urpilainen Portfolio International Partnerships Attending - Renaud Savignat (Cabinet member)
-
Date 11 Feb 2020 Location Brussels, Belgium Subject Health In humanitarian aid and in crisis management Cabinet Cabinet of Commissioner Janez Lenarčič Portfolio Crisis Management Attending - Kasia Jurczak (Cabinet member)
-
Date 11 Feb 2020 Location Brussels, Belgium Subject Pharmaceutical strategy Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Olympia Neocleous (Cabinet member)
-
Date 06 Feb 2020 Location Brussels Subject Medical innovation & Reform policies Cabinet Cabinet of Commissioner Elisa Ferreira Portfolio Cohesion and Reforms Attending - Marlene Madsen (Cabinet member)
-
Date 23 Jan 2020 Location Brussels Subject presentation EFPIA's manifesto Cabinet Cabinet of Commissioner Phil Hogan Portfolio Agriculture & Rural Development Attending - Dermot Ryan (Cabinet member)
-
Date 23 Jan 2020 Location Brussels Subject Integrated health solutions, active ageing, sustainability and quality of healthcare systems, long-term visions on healthcare Cabinet Cabinet of Vice-President Dubravka Šuica Portfolio Democracy and Demography Attending - Astrid Dentler (Cabinet member)
-
Date 23 Jan 2020 Location Brussels Subject presentation EFPIA's manifesto Cabinet Cabinet of Commissioner Phil Hogan Attending - Dermot Ryan (Cabinet member)
-
Date 29 Aug 2019 Location Brussels Subject EFPIA position on the EU preliminary list of US products considered for countermeasures Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Arunas Ribokas (Cabinet member)
-
Date 29 Aug 2019 Location Brussels Subject Trade in the pharma sector Cabinet Cabinet of Vice-President Cecilia Malmström Portfolio Trade Attending - Miguel Ceballos Baron (Cabinet member)
-
Date 23 Jul 2019 Location BREY-Brussels Subject Present their latest Manifesto and introduce the pharmaceutical companies position towards new Commission DG Internal Market, Industry, Entrepreneurship and SMEs Attending - Timo Pesonen (Acting Director-General)
-
Date 26 Jun 2019 Location Brussels Subject Access to medicines, shortages, medicines for rare diseases and children Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Vytenis Andriukaitis (Commissioner)
- Alina Timofte (Cabinet member)
- Arunas Vinciunas (Cabinet member)
-
Date 25 Jun 2019 Location Brussels Subject development of a High-level Forum on Healthcare; the Commission "outcomes" agenda; EU HTA Regulation proposal DG Health and Food Safety Attending - Anne Bucher (Director-General)
-
Date 23 Apr 2019 Location BRUSSELS Subject PPPs in health area DG Research and Innovation Attending - Jean-Eric Paquet (Director-General)
-
Date 04 Feb 2019 Location Brussels Subject Supplementary Protection Certificate Manufacturing Waiver in Europe and EFPIA’s priorities in the context of the 2019 institutional changes Cabinet Cabinet of Vice-President Jyrki Katainen Portfolio Jobs, Growth, Investment and Competitiveness Attending - Jyrki Katainen (Vice-President)
-
Date 03 Dec 2018 Location Brussels, Belgium Subject courtesy visit DG Health and Food Safety Attending - Anne Bucher (Director-General)
-
Date 07 Sep 2018 Location Brussels Subject Partnesrhips DG Research and Innovation Attending - Jean-Eric Paquet (Director-General)
-
Date 15 Jun 2018 Location Brussels, Berl Subject HTA Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Vytenis Andriukaitis (Commissioner)
- Annika Nowak (Cabinet member)
Other Lobbyists -
Date 19 Apr 2018 Location Brussels Subject Competitiveness of the European Pharmaceutical industry Cabinet Cabinet of Vice-President Jyrki Katainen Portfolio Jobs, Growth, Investment and Competitiveness Attending - Risto Artjoki (Cabinet member)
-
Date 21 Mar 2018 Location Brussels Subject competitiveness of the life science industry in Europe Cabinet Cabinet of Vice-President Günther Oettinger Portfolio Budget & Human Resources Attending - Michael Hager (Cabinet member)
-
Date 19 Mar 2018 Location Brussels Subject Health in development cooperation Cabinet Cabinet of Vice-President Neven Mimica Portfolio International Cooperation & Development Attending - Nils Behrndt (Cabinet member)
-
Date 15 Mar 2018 Location Brussels Subject Research & Innovation policy Cabinet Cabinet of Commissioner Tibor Navracsics Portfolio Education, Culture, Youth and Sport Attending - Patricia Reilly (Cabinet member)
-
Date 08 Feb 2018 Location Brussels Subject Possible change of EU patent legislation Cabinet Cabinet of Vice-President Cecilia Malmström Portfolio Trade Attending - Nele Eichhorn (Cabinet member)
- Maria Asenius (Cabinet member)
-
Date 30 Jan 2018 Location Brussels Subject Exchange of views on current topics Cabinet Cabinet of Commissioner Elżbieta Bieńkowska Portfolio Internal Market, Industry, Entrepreneurship and SMEs Attending - Fabrice Comptour (Cabinet member)
- Elżbieta Bieńkowska (Commissioner)
-
Date 17 Jan 2018 Location Brussels Subject Role of pharmaceutical industry in development cooperation Cabinet Cabinet of Vice-President Neven Mimica Portfolio International Cooperation & Development Attending - Irena Andrassy (Cabinet member)
- Nils Behrndt (Cabinet member)
-
Date 12 Jan 2018 Location Brussels Subject Discussion on AMR DG Health and Food Safety Attending - Xavier Prats Monné (Director-General)
-
Date 15 Dec 2017 Location BRUSSELS Subject AMR; Pharma Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)
-
Date 29 Nov 2017 Location Brussels Subject Pharmaceutical incentives, antimicrobial resistance Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)
- Vytenis Andriukaitis (Commissioner)
Other Lobbyists -
Date 27 Oct 2017 Location BRUSSELS Subject Meeting with the Task Force for the Preparation and Conduct of the Negotiations with the United Kingdom under Article 50 TEU DG Task Force for Relations with the United Kingdom Attending - Michel Barnier (Head of Task Force)
Other Lobbyists -
Date 29 Jun 2017 Location Brussels Subject Turkey - in breach of rules; Canada - some concerns around implementing legislation. Cabinet Cabinet of Vice-President Cecilia Malmström Portfolio Trade Attending - Christian Burgsmueller (Cabinet member)
- Maria Asenius (Cabinet member)
-
Date 24 Apr 2017 Location Brussels Subject Follow-up to COUNCIL conclusions: Impact of the incentives on innovation, availability and accessibility of medicinal products Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)
-
Date 31 Jan 2017 Location Brussels Subject Non Communicable diseases Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)
-
Date 07 Dec 2016 Location Brussels Subject Meeting with EPFIA'S President, IMI/Innovation Policy Cabinet Cabinet of Commissioner Carlos Moedas Portfolio Research, Science and Innovation Attending - Carlos Moedas (Commissioner)
- Giulia Del Brenna (Cabinet member)
-
Date 07 Oct 2016 Location Brussels, Belgium Subject GDPR Cabinet Cabinet of Commissioner Věra Jourová Portfolio Justice, Consumers and Gender Equality Attending - Kevin O'Connell (Cabinet member)
-
Date 15 Jun 2016 Location Brussels Subject HTA, AMR, Access to innovative medicines Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)
- Vytenis Andriukaitis (Commissioner)
-
Date 03 Jun 2016 Location Brussels Subject AMR, Situation in Ukraine Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)
- Vytenis Andriukaitis (Commissioner)
-
Date 24 Feb 2016 Location Brussels Subject TTIP, CETA, affordable medicines Cabinet Cabinet of Vice-President Cecilia Malmström Portfolio Trade Attending - Cecilia Malmström (Commissioner)
-
Date 24 Feb 2016 Location Brussels Subject Access to Medicines, HTA, AMR Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)
- Vytenis Andriukaitis (Commissioner)
-
Date 24 Feb 2016 Location Brussels Subject Big Data, ehealth DG Günther Oettinger Attending - Günther Oettinger (Commissioner)
-
Date 23 Feb 2016 Location Brussels, Belgium Subject Access to health care and pharmaceuticals in developing countries Cabinet Cabinet of Vice-President Neven Mimica Portfolio International Cooperation & Development Attending - Nils Behrndt (Cabinet member)
-
Date 25 Nov 2015 Location Brussels Subject AMR DG Health and Food Safety Attending - Xavier Prats Monné (Director-General)
-
Date 19 Nov 2015 Location Brussels Subject TTIP Cabinet Cabinet of Vice-President Cecilia Malmström Portfolio Trade Attending - Miguel Ceballos Baron (Cabinet member)
- Maria Asenius (Cabinet member)
Other Lobbyists -
Date 28 May 2015 Location Brussels, Belgium Subject Developments of pharmaceutical industry Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Arunas Vinciunas (Cabinet member)
-
Date 22 Apr 2015 Location Brussels Subject Trade relations with US and China DG Trade Attending - Jean-Luc Demarty (Director-General)
-
Date 25 Feb 2015 Location Brussels Subject Trade negotiations and health Cabinet Cabinet of Vice-President Cecilia Malmström Portfolio Trade Attending - Cécile Billaux (Cabinet member)
-
Date 10 Feb 2015 Location Brussels Subject Science and innovation Cabinet Cabinet of Commissioner Carlos Moedas Portfolio Research, Science and Innovation Attending - Antonio Lowndes Marques De Araujo Vicente (Cabinet member)
-
Date 10 Feb 2015 Location Brussels Subject TTIP Cabinet Cabinet of Vice-President Cecilia Malmström Portfolio Trade Attending - Maria Asenius (Cabinet member)
- Miguel Ceballos Baron (Cabinet member)
-
Date 26 Jan 2015 Location Brussels, Belgium Subject Anti-biotic resistance within development policy Cabinet Cabinet of Vice-President Neven Mimica Portfolio International Cooperation & Development Attending - Paolo Berizzi (Cabinet member)
-
Date 23 Jan 2015 Location Brussels, Belgium Subject EFPIA engagement in developing countries Cabinet Cabinet of Vice-President Neven Mimica Portfolio International Cooperation & Development Attending - Nils Behrndt (Cabinet member)
-
Date 19 Dec 2014 Location Brussels Subject Innovative Medecines Initiative / Ebola crisis Cabinet Cabinet of Commissioner Carlos Moedas Portfolio Research, Science and Innovation Attending - Giulia Del Brenna (Cabinet member)
-
Date 18 Dec 2014 Location Brussels Subject European industry’s perspective on the future of EU research and innovation policy Cabinet Cabinet of Commissioner Carlos Moedas Portfolio Research, Science and Innovation Attending - Carlos Moedas (Commissioner)
- Meetings